Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Sarah L. Pett, Ken M. Kunisaki, Deborah Wentworth, Timothy J. Griffin, Ioannis Kalomenidis, Raquel Nahra, Rocio Montejano Sanchez, Shane W. Hodgson, Kiat Ruxrungtham, Dominic Dwyer, R. T. Davey, Chris H. Wendt, J. Lundgren, P. Jansson, M. Pearson, B. Aagaard, F. Hudson, R. Bennet, F. Pacciarini, B. AngusN. Paton, Y. Collaco Moraes, D. Cooper, S. Pett, S. Emery, D. Courtney-Rogers, R. Robson, F. Gordin, A. Sanchez, B. Standridge, M. Vjecha, A. Moricz, M. Delfino, W. Belloso, M. Losso, K. Tillmann, G. Touloumi, V. Gioukari, O. Anagnostou, A. La Rosa, M. J. Saenz, P. Lopez, P. Herrero, B. Portas, A. Avihingsanon, K. Ruxrungtham, P. Kaewon, E. Denning, N. Engen, J. D. Neaton, For the INSIGHT FLU003 Plus Study Group
Dive into the research topics of 'Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study'. Together they form a unique fingerprint.